Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

FATE

FATE THERAPEUTICS INC

CIK 0001434316 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$2.33
↓ 0.12 (-4.90%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options

Key stats

Market Cap
$271.58M
P/E Ratio
-2.16
EPS
-1.15
Dividend Yield
Not covered
52W Position
61%
Beta
1.94

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
1.77
P/S
41.84
EV/Revenue
36.84
ROE
-82.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 61%
$0.93$3.23

Latest Financials

2025-12-31 FY
Revenue
$6.65M
Net Income
-$136.31M
Total Assets
$318.94M
Free Cash Flow
-$112.04M

Recent news